These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 17617291

  • 1. Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.
    Yablon SA, Brashear A, Gordon MF, Elovic EP, Turkel CC, Daggett S, Liu J, Brin MF.
    Clin Ther; 2007 Apr; 29(4):683-90. PubMed ID: 17617291
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 3. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C.
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J, Bogucki A, Reclawowicz D.
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [Abstract] [Full Text] [Related]

  • 6. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.
    Turkel CC, Bowen B, Liu J, Brin MF.
    Arch Phys Med Rehabil; 2006 Jun; 87(6):786-92. PubMed ID: 16731213
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
    Luauté J, Landrault E, Jacquin-Courtois S, Mertens P, Rode G, Boisson D.
    Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
    [Abstract] [Full Text] [Related]

  • 8. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.
    Brin MF, Comella CL, Jankovic J, Lai F, Naumann M, CD-017 BoNTA Study Group.
    Mov Disord; 2008 Jul 30; 23(10):1353-60. PubMed ID: 18546321
    [Abstract] [Full Text] [Related]

  • 9. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity.
    Suputtitada A, Suwanwela NC.
    Disabil Rehabil; 2005 Feb 18; 27(4):176-84. PubMed ID: 15824048
    [Abstract] [Full Text] [Related]

  • 10. Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: much ado about nothing?
    Lange O, Bigalke H, Dengler R, Wegner F, deGroot M, Wohlfarth K.
    Clin Neuropharmacol; 2009 Feb 18; 32(4):213-8. PubMed ID: 19620852
    [Abstract] [Full Text] [Related]

  • 11. Botulinum treatment for post-stroke spasticity: low dose regime.
    Viriyavejakul A, Vachalathiti R, Poungvarin N.
    J Med Assoc Thai; 1998 Jun 18; 81(6):413-22. PubMed ID: 9676073
    [Abstract] [Full Text] [Related]

  • 12. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine.
    Saper JR, Mathew NT, Loder EW, DeGryse R, VanDenburgh AM, BoNTA-009 Study Group.
    Pain Med; 2007 Sep 18; 8(6):478-85. PubMed ID: 17716321
    [Abstract] [Full Text] [Related]

  • 13. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity.
    Kong KH, Neo JJ, Chua KS.
    Clin Rehabil; 2007 Jan 18; 21(1):28-35. PubMed ID: 17213238
    [Abstract] [Full Text] [Related]

  • 14. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F, Sandrini G, Moglia A, Nappi G, Pacchetti C.
    Neurol Sci; 2005 Apr 18; 26(1):26-31. PubMed ID: 15877184
    [Abstract] [Full Text] [Related]

  • 15. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
    Mathew NT, Kailasam J, Meadors L.
    Headache; 2008 Feb 18; 48(2):194-200. PubMed ID: 17868356
    [Abstract] [Full Text] [Related]

  • 16. Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.
    Yablon SA, Brin MF, VanDenburgh AM, Zhou J, Garabedian-Ruffalo SM, Abu-Shakra S, Beddingfield FC.
    Mov Disord; 2011 Feb 01; 26(2):209-15. PubMed ID: 20960474
    [Abstract] [Full Text] [Related]

  • 17. A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.
    Relja M, Poole AC, Schoenen J, Pascual J, Lei X, Thompson C, European BoNTA Headache Study Group.
    Cephalalgia; 2007 Jun 01; 27(6):492-503. PubMed ID: 17428299
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P, Slawek J, Denes Z, Platz T, Comes G, Grafe S, Pulte I.
    J Rehabil Med; 2011 May 01; 43(6):486-92. PubMed ID: 21533328
    [Abstract] [Full Text] [Related]

  • 19. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ, Glaser DA, Eadie N, Daggett S, Kowalski JW, Lai PY, North American Botox in Primary Axillary Hyperhidrosis Clinical Study Group.
    J Am Acad Dermatol; 2007 Apr 01; 56(4):604-11. PubMed ID: 17306417
    [Abstract] [Full Text] [Related]

  • 20. Combined effects of botulinum toxin and casting treatments on lower limb spasticity after stroke.
    Farina S, Migliorini C, Gandolfi M, Bertolasi L, Casarotto M, Manganotti P, Fiaschi A, Smania N.
    Funct Neurol; 2008 Apr 01; 23(2):87-91. PubMed ID: 18671909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.